These lab-built possibilities were not created with recreational use in mind. In the nineteen nineties, John W. Huffman as well as a workforce of fellow chemists at Clemson University made some of the 1st formulation for artificial cannabinoid receptor agonists (SCRAs), a relatives of substances that imitate the physiological and psychological impa